Valiant Laboratories
VALIANTLAB · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 6, 2023

Stock Price vs Company Growth
1d
1.5%
1w
1.3%
1m
14.4%
3m
10.3%
6m
11.2%
1y
39.7%
all
27.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 64 1.5%
58
83.2
Company Overview

Sales
237 Cr
Growth: 16.4%
Profit after Tax
-3.28 Cr
Growth: -24.4%
Micro Cap
348 Cr
P/S: 1.5x
Industry P/S: 2.7x
Fundamentals

Sales (Cr) ₹ 237
Growth 16.4%
EBITDA 2.7%
P/S 1.5x
Dividend 0.0%
P/E -106.2x
Book Value ₹ 10
PEG Ratio -6.3x
ROE -6.3%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Valiant Laboratories is a leading Active Pharmaceutical ingredient manufacturing company with its focus on manufacturing Paracetamol API/Bulk Drug which has several applications like uses in treatment of conditions such as headache, muscle ache, arthritis, back ache, toothache, cold and fever. Product of the companyParacetamol/AcetaminophenKey events and milestones1980: Formed Bharat Chemicals (a partnership firm).1981: Acquired plot No.